Chon Lai

470 total citations
10 papers, 364 citations indexed

About

Chon Lai is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chon Lai has authored 10 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Public Health, Environmental and Occupational Health. Recurrent topics in Chon Lai's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Genomics and Chromatin Dynamics (2 papers). Chon Lai is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Genomics and Chromatin Dynamics (2 papers). Chon Lai collaborates with scholars based in United States, Switzerland and Italy. Chon Lai's co-authors include Lihong Shi, Todd Vo, Barry Quart, Ryan Stansfield, Andreas Maderna, Li‐Tain Yeh, Gary Larson, Jeffrey N. Miner, James M. Veal and Cory Iverson and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The American Journal of Gastroenterology.

In The Last Decade

Chon Lai

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chon Lai United States	6	286	72	57	41	32	10	364
Takaharu Hirayama Japan	8	186 0.7×	82 1.1×	115 2.0×	31 0.8×	28 0.9×	9	356
Da-Qiang Li China	11	334 1.2×	139 1.9×	44 0.8×	45 1.1×	20 0.6×	19	425
Hon Yan Kelvin Yip Australia	7	177 0.6×	106 1.5×	58 1.0×	20 0.5×	28 0.9×	9	321
Fulvia Roletto Italy	9	174 0.6×	87 1.2×	72 1.3×	26 0.6×	38 1.2×	12	303
Min‐Wu Chao Taiwan	15	364 1.3×	149 2.1×	86 1.5×	31 0.8×	31 1.0×	26	492
Claire McWhirter United Kingdom	5	394 1.4×	79 1.1×	48 0.8×	46 1.1×	45 1.4×	8	478
James Zweibel United States	8	258 0.9×	123 1.7×	26 0.5×	27 0.7×	39 1.2×	10	370
Grazia Saturno Italy	8	232 0.8×	125 1.7×	17 0.3×	23 0.6×	16 0.5×	12	353
Henrik Moebitz Switzerland	5	325 1.1×	119 1.7×	105 1.8×	54 1.3×	30 0.9×	8	441
Soo‐Yeon Hwang South Korea	10	220 0.8×	115 1.6×	57 1.0×	16 0.4×	65 2.0×	22	374

Countries citing papers authored by Chon Lai

Since Specialization

Citations

This map shows the geographic impact of Chon Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chon Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chon Lai more than expected).

Fields of papers citing papers by Chon Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chon Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chon Lai. The network helps show where Chon Lai may publish in the future.

Co-authorship network of co-authors of Chon Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Chon Lai. A scholar is included among the top collaborators of Chon Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chon Lai. Chon Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shakya, Arvind, Qiao Liu, Chon Lai, et al.. (2025). Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders. Journal of Translational Autoimmunity. 11. 100329–100329.

Martínez‐Terroba, Elena, Arvind Shakya, Chon Lai, et al.. (2024). Cereblon-based Bifunctional Degrader of SOS1, BTX-6654, Targets Multiple KRAS Mutations and Inhibits Tumor Growth. Molecular Cancer Therapeutics. 23(4). 407–420. 4 indexed citations

Bortolato, Andrea, Yongnian Sun, Chon Lai, et al.. (2023). On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations. Journal of Chemical Information and Modeling. 63(8). 2382–2392. 15 indexed citations

Kanouni, Toufike, Christophe Severin, Natalie Yuen, et al.. (2020). Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1). Journal of Medicinal Chemistry. 63(23). 14522–14529. 92 indexed citations

Nie, Zhe, Lihong Shi, Chon Lai, et al.. (2018). Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(1). 103–106. 12 indexed citations

Nie, Zhe, Lihong Shi, Chon Lai, et al.. (2018). Structure-based design and discovery of potent and selective KDM5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(9). 1490–1494. 32 indexed citations

Chen, Young K., Tiziana Bonaldi, Alessandro Cuomo, et al.. (2017). Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models. ACS Medicinal Chemistry Letters. 8(8). 869–874. 51 indexed citations

Iverson, Cory, Gary Larson, Chon Lai, et al.. (2009). RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer. Cancer Research. 69(17). 6839–6847. 153 indexed citations

Miampamba, Marcel, et al.. (2008). RDEA119, a Potent and Highly Selective MEK1/2 Inhibitor Is Beneficial in Dextran Sulfate Sodium (DSS)-Induced Chronic Colitis in Mice. The American Journal of Gastroenterology. 103. S453–S453. 2 indexed citations

10.

Hamatake, Robert, Li‐Tain Yeh, Hong Kim, et al.. (2007). RDEA119: A potent and highly selective MEK inhibitor for the treatment of cancer. Molecular Cancer Therapeutics. 6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact